首页|老年帕金森病患者临床用药的风险管理

老年帕金森病患者临床用药的风险管理

扫码查看
帕金森病(Parkinson's disease,PD)是老年人高发疾病,发病率随年龄增长呈上升趋势,严重影响老年人的生活质量.老年人群存在多病共患、多重用药、对治疗方案敏感性偏低等特点,导致在PD治疗用药期间不仅应关注药物的疗效,也需充分考虑药品使用的风险.药品使用风险管理将医疗机构内药品按照使用环节梳理,识别各环节风险点、制定预防和监测措施,确保用药风险最小化.本文以老年PD患者治疗药物为例,利用该模式,收集老年PD患者治疗用药药品信息内容,结合临床用药实践,识别药品遴选、采购与储存、处方与调配、特殊人群用药等环节风险点、产生风险的原因并提出相应的管理措施,规范老年PD患者治疗的风险管理,完善该领域药学服务,推动老年PD患者临床合理用药.
Promotion of rational medication use in elderly patients with Parkinson's disease through drug use risk management
Parkinson's disease(PD)is a prevalent condition among the elderly,with its incidence increasing with age and significantly affecting the quality of life in this demographic.Given the unique characteristics of older adults,such as comorbidities,polypharmacy,and reduced sensitivity to treatment regimens,it is essential to not only focus on the efficacy of medications used in PD treatment but also to carefully evaluate the associated drug risks.This article examines a drug risk management approach for treating elderly patients with PD,emphasizing the importance of gathering comprehensive drug information,identifying potential risks associated with drug selection,procurement,storage,prescription,and dispensing,and addressing specific considerations pertinent to the elderly population.Furthermore,the article proposes management strategies aimed at standardizing risk management in the treatment of elderly patients with PD,enhancing clinical pharmacy services in this area,and promoting rational drug use among this vulnerable group.

Parkinson diseaseRational use of drugRisk management of drug use

孙雪林、钱东方、赵文靖、汪熙、张亚同、胡欣

展开 >

北京医院药学部 国家老年医学研究中心 中国医学科学院老年医学研究院,北京 100730

北京北方医药健康经济研究中心,北京 100021

帕金森病 合理用药 药品使用风险管理

2024

中华老年医学杂志
中华医学会

中华老年医学杂志

CSTPCD北大核心
影响因子:1.606
ISSN:0254-9026
年,卷(期):2024.43(11)